Eurobiosimilars Conferences Readership Profiles: Key Metrics (Source: Google Analytics)

The dashboard of Google Analytics traffic overview of “17th European Biosimilars Congress” clearly reflects the interests of the global enthusiastic conference attendees like Pharmacists and Pharmacologist, Researchers, Industrialists , Health care professionals, Industrial Experts and Psychiatrist from around the globe who are searching to attend and  present/exhibit  their research/organization findings on highly acknowledged international conferences like ours with the web traffic a total of about 22,114 visits. The total page views were close to 101,004 where our reports are analysed half yearly.

  • More than 70000 Visitors visiting conference website to attend and submit proposals Highest number of Visitors reporting both from the developed and developing nations.
  • For Under developing nations researchers our conference website is yardstick to quantify their research proposal submitted
  • Majority of the visitors have come from countries/territories like United States of America, United Kingdom, United Arab Emirates, Brazil, Canada, Mexico, Australia, China, India, Hong Kong, Indonesia, Japan, Malaysia, Thailand, New Zealand, Philippines, Singapore, Taiwan, Thailand, South Korea, Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, Spain, Switzerland, Turkey and Ukraine
  • Highest number of Visitors reporting both from the developed and developing nations.
  • Penetrating the study of visitor, navigation, and traffic patterns to determine the success of our conference website majority amount of traffic we receive from cities like Austin, Boston, Chicago, Dallas, Denver, Houston, Los Angeles, Nashville, New York, Philadelphia, Phoenix, San Antonio, San Diego, Seattle, Washington, Toronto, Montreal, Vancouver, Berlin, Barcelona, Paris, Edinburgh, London, Rome, Valencia, Zurich, Copenhagen, Athens, Moscow, Vienna, Sydney, Melbourne, Beijing, Hyderabad, Tokyo, Singapore, Seoul, Auckland, Cairo, Dubai, Riyadh and Istanbul.
  • Average Time spent by each visitor on Site is over 2.00 Minute.

The Traffic Sources mentions that the number of Unique Visitors of the website listing from academic professionals and medical industries, research organizations, healthcare companies.

Reasons behind listing Euro Biosimilars 2024 top of search engines: (Source: Google)

  • Researchers are inclined only to the conferences where their profiles and abstracts get highest visibility and readership.
  • The most accessible way for researchers to grow their research profiles is through their contributions with a conference presentation at our conference.
  • Our Conference provides opportunities to network and meet other researchers in their field and establish potential contacts for future positions.
  • Attending and presenting at our conference would contribute to learn about the most recent advances in their field.
  • Get an opportunity to publish full paper in our international journals with high impact factors on Special issues.

Besides all these factors we also create individual speaker pages where their accepted biographies and abstracts are updated on regular basis for promoting their web presence in all the search engine listings and Social Networking Channels.

With 10 years now added to its repertoire, European Biosimilars Congress is really turning into a staple meeting where Biosimilars partners accumulate to address the present and future condition of Biosimilars in the Europe.

The addition of two dedicated streams at the European Biosimilars Congress meeting proved to be highly successful, providing valuable insights from two distinct groups. One group excelled in the scientific and technical aspects, offering in-depth knowledge and expertise in research and manufacturing. The other group excelled in the business and strategic aspects, providing valuable insights into market trends, commercialization strategies, and regulatory considerations. This dual-stream approach allowed participants to gain a comprehensive understanding of both the scientific and commercial aspects of the biosimilars industry. The positive response and knowledge exchange from these two specialized streams contributed to the overall success of the European Biosimilars Congress meeting.

The 2024 establishment of this meeting will enable us to keep on diving further into both the investigation of Biosimilars improvement – and the business requirements for organizations that keep on seeking FDA endorsement.

The Organizing Committee is delighted to invite you to attend the Euro Biosimilars one of its remarkable Pharmaceutical conferences, to be held during April 04-05, 2024 at Madrid, SpainEuropean Biosimilars Congress is a global annual event. This European Biosimilars Congress 2024 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

At Euro Bisimilars 2024 meet your target audiences from around the world focused on learning about biologics and Biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and Biosimilars community.

2022 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 10+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Euro Biosimilars 2024 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Biosimilars & Biologics, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Bioanalysis and Biomedicine International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

The Euro Biosimilars 2024 conference will host a diverse range of exhibitors, with over 50+ organizations and international pavilions participating. The exhibition will feature a wide array of industry stakeholders, including equipment manufacturers, suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies. This diverse representation underscores the significance and breadth of the biosimilars sector. Attendees can expect to engage with leading companies and institutions from various sectors, fostering collaborations, knowledge exchange, and advancements in the field of biosimilars.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Euro Biosimilars 2024 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Target Audience:

  • Directors, CEO’s of Organizations
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Bioslogics Industries
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Patent Attorneys
  • Intellectual Property Attorneys
  • Investment Analysts
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs

Global Internet users for conferenceseries.com: Statistical representation (Source: Google Analytics)

Flip on the other side Conferenceseries  world’s leading specialist in organizing scientific conferences, events trade, and consumer exhibitions both domestically and internationally in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business attracting more than 25 Million+ Visitors, 25000+ unique visitors per conference and 70000+ page views for every individual conference would help in quantifying our presenters research and biography visibility to the online communities and get recognized worldwide.

Conference Series Web Metrics at Glance: Source: Google Analytics

  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Out of the 500,000 listing worldwide major conferences attended by 2.5 million attendees 16.8% attendees are drawing only from our Medical, Pharma, Healthcare, Nursing, Engineering, Science, Technology and Business conferences. The main reasons behind the increased popularity of our conference attendees is because of the changing mindsets of academicians, researchers and industries in exploring the opportunities for exchanging ideas, sharing resources, building networks and increase awareness of the on the recent happenings in their research around the world.

“Attending and presenting at conferences remains as the most favorable model of knowledge dissemination for researchers and practitioners to keep abreast of all advances in their field, presenting state-of-the-art research usually on a variety of subjects”

We will continue to set our bar higher and make further progress to organize 1000 conferences in 50 countries across all continents by 2018. We have recently launched online digital video library where all our conference proceedings would be shared and be accessed by the online communities freely.

Channels for driving additional traffic to your research

Web Analytics are best means of measuring concrete details like how many people are visiting our websites, how many of those visitors are the unique visitors and how many of them are staying long to view the complete information available in our sites. The following snapshots of some of our websites will clearly depict the metrics how our conferences stand at par to the other conferences in terms of Visibility, outreach, Participation Number and relevance to their subject.

The metrics of these websites represents more than 25+ Million visitors in addition to this we also equipped with 10 additional scientific websites represents 10+ Million visitors traffic to our conference websites.

A statistical representation of global users for www.omicsonline.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.omicsonline.com (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.esciencecentral.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.scitechnol.com (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.omicsgroup.org (Source: Google Analytics)

Visitor Analysis Report

A statistical representation of global users for www.conferenceseries.com (Source: Google Analytics)

Visitor Analysis Report